Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T900607-sodium in Previously Treated Gastric Cancer or Esophageal Adenocarcinoma
NCT00048529Phase 2Suspended
- Sponsor
- Tularik Inc.
- Start
- Sep 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of t900607-sodium in gastric cancer (GC), esophageal adenocarcinoma (EAC), sponsored by Tularik Inc.. Started Sep 2002; status: suspended.
02
Drugs
t900607-sodium
03
Conditions
gastric cancer (GC)esophageal adenocarcinoma (EAC)
Beyond the preview
Go deeper on NCT00048529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00048529.